ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $407,000 | +1353.6% | 12,900 | +2604.4% | 0.00% | – |
| Q4 2019 | $28,000 | -59.4% | 477 | -74.7% | 0.00% | – |
| Q3 2019 | $69,000 | +27.8% | 1,889 | +62.3% | 0.00% | – |
| Q2 2019 | $54,000 | +5300.0% | 1,164 | +11540.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 10 | -91.9% | 0.00% | – |
| Q4 2016 | $2,000 | -99.5% | 124 | -99.6% | 0.00% | -100.0% |
| Q3 2016 | $413,000 | +18.7% | 29,855 | -15.2% | 0.00% | 0.0% |
| Q2 2016 | $348,000 | +23.0% | 35,219 | +193.5% | 0.00% | 0.0% |
| Q3 2015 | $283,000 | -42.4% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $491,000 | -11.7% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $556,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |